All In Biotech

Drug Trial Radar · NCT07870239

Comparison of Topical Antibiotics Versus Systemic Antibiotics in Preventing Burn Wound Infection in Pediatric Burn Patients

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 222 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

222

Planned (sponsor's estimate)

Start

Nov 5, 2026

Primary completion

May 5, 2027

Study completion May 5, 2027

Sponsor

Lead sponsor
abdul mateenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 5 years, up to 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Burn wound infection is a common complication in children with burns and can delay healing and increase the risk of complications. This randomized controlled trial will compare two antibiotic strategies for preventing infection in pediatric burn patients. One group will receive topical antibiotics alone, while the other group will receive topical antibiotics along with systemic antibiotics. The study will compare the occurrence of burn wound infection between the two groups to determine whether adding systemic antibiotics provides additional benefit in preventing infection.

Conditions

  • Burn

Interventions

  • Silver Sulfadiazine Cream 1%Drug

    Silver sulfadiazine 1% cream applied once daily to the burn wound according to the departmental protocol

  • Amoxicillin and clavulanateDrug

    Amoxicillin plus clavulanate at a total dose of 50 mg/kg/day, administered three times daily according to the departmental protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of burn wound infectionTime frame: From initiation of treatment through the 14-day follow-up visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • King Edward Medical University

    Lahore, Punjab Province, Pakistan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.